Trends of Clinical Trials for Drug Development in Rare Diseases.

CONCLUSION: This study revealed details of the three registries and bias among rare diseases in the number of the trials. This information could contribute to drug-repositioning and a broad range of rare disease studies.
PMID: 29866013 [PubMed - as supplied by publisher]

Source: Current Clinical Pharmacology - June 3, 2018 Category: Drugs & Pharmacology Authors: Sakate R, Fukagawa A, Takagaki Y, Okura H, Matsuyama A Tags: Curr Clin Pharmacol Source Type: research